Detalhe da pesquisa
1.
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 24(22)2023 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38003295
2.
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models.
Biol Blood Marrow Transplant
; 23(11): 1847-1851, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28729148
3.
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.
Blood
; 124(4): 638-44, 2014 Jul 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24923299
4.
T regulatory cell separation for clinical application.
Transfus Apher Sci
; 47(2): 213-6, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22795999
5.
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia.
Blood Adv
; 5(5): 1199-1208, 2021 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33646302
6.
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 25(24): 7540-7553, 2019 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31578228
7.
Graft engineering for allogeneic haploidentical stem cell transplantation.
Blood Cells Mol Dis
; 33(3): 274-80, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15528144